Medicus Pharma Ltd.
MDCX
$0.30
-$0.04-10.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.20M | 5.02M | 4.58M | 3.12M | 2.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.79M | 6.71M | 6.02M | 5.13M | 3.59M |
| Operating Income | -7.79M | -6.71M | -6.02M | -5.13M | -3.59M |
| Income Before Tax | -15.07M | -20.94M | -6.18M | -5.10M | -3.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.07M | -20.94M | -6.18M | -5.10M | -3.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.00 | 100.00 | -- | -- | -- |
| Net Income | -15.07M | -20.94M | -6.18M | -5.10M | -3.54M |
| EBIT | -7.79M | -6.71M | -6.02M | -5.13M | -3.59M |
| EBITDA | -- | -- | -- | -- | -3.56M |
| EPS Basic | -0.81 | -1.12 | -0.43 | -0.42 | -0.31 |
| Normalized Basic EPS | -0.50 | -0.39 | -0.26 | -0.26 | -0.19 |
| EPS Diluted | -1.62 | -1.12 | -0.43 | -0.42 | -0.31 |
| Normalized Diluted EPS | -0.50 | -0.39 | -0.26 | -0.26 | -0.19 |
| Average Basic Shares Outstanding | 18.60M | 18.63M | 14.28M | 12.24M | 11.37M |
| Average Diluted Shares Outstanding | 18.60M | 18.63M | 14.28M | 12.24M | 11.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |